Search Results

There are 8489 results for: content related to: Nigrostriatal dysfunction in homozygous and heterozygous parkin gene carriers: An 18 F-dopa PET progression study

  1. Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and parkin-linked Parkinson's disease

    Movement Disorders

    Volume 21, Issue 3, March 2006, Pages: 299–305, Michele T.M. Hu, Christoph Scherfler, Naheed L. Khan, Jo V. Hajnal, Andrew J. Lees, Niall Quinn, Nicholas W. Wood and David J. Brooks

    Version of Record online : 6 OCT 2005, DOI: 10.1002/mds.20702

  2. Occurrence of giant focal forms of congenital hyperinsulinism with incorrect visualization by 18F DOPA-PET/CT scanning

    Clinical Endocrinology

    Volume 81, Issue 6, December 2014, Pages: 847–854, Peter Kühnen, Ritana Matthae, Ved Arya, Kathrin Hauptmann, Karin Rothe, Simon Wächter, Michael Singer, Wolfgang Mohnike, Traugott Eberhard, Klemens Raile, Lina M. Lauffer, Roman Iakoubov, Khalid Hussain and Oliver Blankenstein

    Version of Record online : 19 MAY 2014, DOI: 10.1111/cen.12473

  3. Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: An 18F-dopa PET study

    Annals of Neurology

    Volume 52, Issue 6, December 2002, Pages: 849–853, Naheed L. Khan, Enza Maria Valente, Anna Rita Bentivoglio, Nicholas W. Wood, Alberto Albanese, David J. Brooks and Paola Piccini

    Version of Record online : 22 NOV 2002, DOI: 10.1002/ana.10417

  4. Imaging end points for monitoring neuroprotection in Parkinson's disease

    Annals of Neurology

    Volume 53, Issue S3, 2003, Pages: S110–S119, David J. Brooks

    Version of Record online : 24 MAR 2003, DOI: 10.1002/ana.10480

  5. Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study

    Annals of Neurology

    Volume 54, Issue 1, July 2003, Pages: 93–101, Alan L. Whone, Ray L. Watts, A. Jon Stoessl, Margaret Davis, Sven Reske, Claude Nahmias, Anthony E. Lang, Olivier Rascol, Maria J. Ribeiro, Philippe Remy, Werner H. Poewe, Robert A. Hauser and David J. Brooks

    Version of Record online : 14 MAY 2003, DOI: 10.1002/ana.10609

  6. Focal congenital hyperinsulinism managed by medical treatment: a diagnostic algorithm based on molecular genetic screening

    Clinical Endocrinology

    Volume 81, Issue 5, November 2014, Pages: 679–688, Arianna Maiorana, Fabrizio Barbetti, Arianna Boiani, Vittoria Rufini, Milena Pizzoferro, Paola Francalanci, Flavio Faletra, Colin G. Nichols, Chiara Grimaldi, Jean de Ville de Goyet, Jacques Rahier, Jean-Claude Henquin and Carlo Dionisi-Vici

    Version of Record online : 30 JAN 2014, DOI: 10.1111/cen.12400

  7. Upregulation of dopamine D2 receptors in dopaminergic drug-naive patients with parkin gene mutations

    Movement Disorders

    Volume 21, Issue 6, 6 June 2006, Pages: 783–788, Christoph Scherfler, Naheed L. Khan, Nicola Pavese, Andrew J. Lees, Niall P. Quinn, David J. Brooks and Paola P. Piccini

    Version of Record online : 1 MAR 2006, DOI: 10.1002/mds.20811

  8. A scan without evidence is not evidence of absence: Scans without evidence of dopaminergic deficit in a symptomatic leucine-rich repeat kinase 2 mutation carrier

    Movement Disorders

    Volume 31, Issue 3, March 2016, Pages: 405–409, Daryl J. Wile, Katie Dinelle, Nasim Vafai, Jessamyn McKenzie, Joseph K. Tsui, Paul Schaffer, Yu-Shin Ding, Matthew Farrer, Vesna Sossi and A. Jon Stoessl

    Version of Record online : 21 DEC 2015, DOI: 10.1002/mds.26450

  9. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  10. Clinical, 18F-dopa PET, and genetic analysis of an ethnic Chinese kindred with early-onset parkinsonism and parkin gene mutations

    Movement Disorders

    Volume 17, Issue 4, July/August 2002, Pages: 670–675, Ruey-Meei Wu, Din-E Shan, Chen-Ming Sun, Ren-Shyan Liu, Wuh-Liang Hwu, Chun-Hwei Tai, Jennifer Hussey, Andrew West, Katrina Gwinn-Hardy, John Hardy, Judy Chen, Matt Farrer and Sarah Lincoln

    Version of Record online : 10 APR 2002, DOI: 10.1002/mds.10184

  11. Do dopamine agonists or levodopa modify Parkinson's disease progression?

    European Journal of Neurology

    Volume 9, Issue s3, November 2002, Pages: 15–22, K. Marek, D. Jennings and J. Seibyl

    Version of Record online : 11 DEC 2002, DOI: 10.1046/j.1468-1331.9.s3.2.x

  12. Use of functional imaging in parkinsonism and dementia

    Movement Disorders

    Volume 18, Issue S6, September 2003, Pages: 88–95, David J. Burn and John T. O'Brien

    Version of Record online : 4 SEP 2003, DOI: 10.1002/mds.10568

  13. 18F-FDG and new positron emitter radiotracers for detecting recurrent medullary thyroid carcinoma

    Journal of Medical Imaging and Radiation Oncology

    Volume 56, Issue 2, April 2012, Pages: 132–135, MARIA CRISTINA MARZOLA and DOMENICO RUBELLO

    Version of Record online : 13 APR 2012, DOI: 10.1111/j.1754-9485.2012.02353.x

  14. Diagnostic accuracy of [18F]-fluoro-l-dihydroxyphenylalanine positron emission tomography scan for persistent congenital hyperinsulinism in Japan

    Clinical Endocrinology

    Volume 75, Issue 3, September 2011, Pages: 342–346, Michiya Masue, Hironori Nishibori, Seisuke Fukuyama, Akihiko Yoshizawa, Shinya Okamoto, Ryuichiro Doi, Shinji Uemoto, Tetsuji Tokumi, Takeshi Kasai and Tohru Yorifuji

    Version of Record online : 5 AUG 2011, DOI: 10.1111/j.1365-2265.2011.04072.x

  15. Dopamine agonists and Parkinson's disease progression: What can we learn from neuroimaging studies

    Annals of Neurology

    Volume 53, Issue S3, 2003, Pages: S160–S169, Kenneth Marek, Danna Jennings and John Seibyl

    Version of Record online : 24 MAR 2003, DOI: 10.1002/ana.10486

  16. Endogenous dopamine release after pharmacological challenges in Parkinson's disease

    Annals of Neurology

    Volume 53, Issue 5, May 2003, Pages: 647–653, Paola Piccini, Nicola Pavese and David J. Brooks

    Version of Record online : 1 APR 2003, DOI: 10.1002/ana.10526

  17. Proposed neuroimaging criteria for the diagnosis of multiple system atrophy

    Movement Disorders

    Volume 24, Issue 7, 15 May 2009, Pages: 949–964, David J. Brooks, Klaus Seppi and for the Neuroimaging Working Group on MSA

    Version of Record online : 20 MAR 2009, DOI: 10.1002/mds.22413

  18. Plasticity of the nigropallidal pathway in Parkinson's disease

    Annals of Neurology

    Volume 53, Issue 2, February 2003, Pages: 206–213, Alan L. Whone, Robert Y. Moore, Paola P. Piccini and David J. Brooks

    Version of Record online : 28 DEC 2002, DOI: 10.1002/ana.10427

  19. PET/CT in diagnosis of movement disorders

    Annals of the New York Academy of Sciences

    Volume 1228, Issue 1, June 2011, Pages: 93–108, Valentina Berti, Alberto Pupi and Lisa Mosconi

    Version of Record online : 30 JUN 2011, DOI: 10.1111/j.1749-6632.2011.06025.x

  20. Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: A longitudinal β-CIT SPECT study

    Movement Disorders

    Volume 17, Issue 1, January/February 2002, Pages: 45–53, Walter Pirker, Schiva Djamshidian, Susanne Asenbaum, Willibald Gerschlager, Gotthard Tribl, Martha Hoffmann and Thomas Brücke

    Version of Record online : 27 NOV 2001, DOI: 10.1002/mds.1265